Stephen Hahn’s liq­uid biop­sy com­pa­ny Har­bin­ger Health rais­es $140M Se­ries B to launch first can­cer tests by 2025

Last year
Financing
Diagnostics

Ab­cam founder urges in­vestors to vote against Dana­her's $5.7B buy­out, seeks to re­turn as CEO

Last year
People

How aca­d­e­m­ic cen­ters are try­ing to keep their promis­ing drug dis­cov­er­ies out of the ‘val­ley of death’

Last year
Discovery
In Focus

Ger­man ra­dio­phar­ma Ariceum un­veils ear­ly ef­fi­ca­cy sig­nal for lead as­set in neu­roen­docrine can­cers

Last year
R&D

Chica­go AI drug dis­cov­ery shop Evozyne nabs $81M in bid to make new pro­teins

Last year
Financing

Ad­comm rec­om­mends FDA re­ject Brain­Stor­m's ALS drug af­ter com­pa­ny filed over protest

Last year
Cell/Gene Tx
FDA+

Grit­stone inks up to $433M con­tract with BAR­DA for 10,000-per­son Covid-19 vac­cine tri­al

Last year
R&D

Biden ad­min­is­tra­tion doles out $100M to re­search drug-re­sis­tant in­fec­tions

Last year
R&D

Bris­tol My­ers teams with so­cial me­dia in­flu­encer and singer to spark rare heart con­di­tion aware­ness

Last year
Pharma
Marketing

Am­gen read­ies PhI­II tri­al for first Op­di­vo biosim­i­lar, with launch un­like­ly be­fore 2028

Last year
R&D

FDA ap­proves decade-old Pfiz­er drug for rare child­hood leukemia

Last year
FDA+

Blue­bird tweaks part­ner­ship with Lon­za to boost Zyn­te­glo, Skysona man­u­fac­tur­ing ca­pac­i­ty

Last year
Manufacturing

Boehringer agrees to com­ply with CM­S' price ne­go­ti­a­tions over block­buster Jar­diance

Last year
Pharma

FDA+ roundup: Agency re­opens AI dis­cus­sion pa­per for com­ments amid two-day work­shop

Last year
AI
Pharma

Cor­rect­ed: Cardiff’s stock jumps af­ter shar­ing promis­ing PhII da­ta for its PLK1 in­hibitor in pan­cre­at­ic can­cer

Last year
R&D

Théa won't buy Pro­QR's oph­thalmic as­sets; Im­muno­vant’s $130M of­fer­ing; In­ozyme to start piv­otal study in Oc­to­ber

Last year
News Briefing

Gilead stops an­oth­er CD47 study, this time in acute myeloid leukemia

Last year
R&D

Roche bets again on Io­n­is in Hunt­ing­ton’s, Alzheimer's

Last year
Deals

Mi­crosoft’s big health­care ac­qui­si­tion just made its AI notes tool more wide­ly avail­able

Last year
Health Tech

Big Phar­ma-backed Sit­ryx locks an ad­di­tion­al $39M in a Se­ries A raise to ad­vance its im­munometa­bol­ic pipeline

Last year
Startups

First shot at pan-coro­n­avirus vac­cine dis­ap­points in VBI Vac­cines study

Last year
R&D

Ex­clu­sive: Ko­mo­do is bet­ting that its newest tool can up­end how health­care da­ta are an­a­lyzed and used

Last year
Health Tech

Ex­clu­sive: CellFE rais­es $22M Se­ries A to ad­vance a new cell ther­a­py man­u­fac­tur­ing idea

Last year
Financing
Cell/Gene Tx

Galec­to lays off 70% of staff, con­sid­ers strate­gic al­ter­na­tives af­ter IPF tri­al fail

Last year
People
First page Previous page 273274275276277278279 Next page Last page
A service from the Financial Times